What Medical Schools Forgot to Teach: How a Generation of American Physicians Is Missing Tuberculosis in Plain Sight

Somewhere between the explosion of genomic medicine and the mounting demands of a modern medical curriculum, tuberculosis quietly lost its seat at the table. For decades, the assumption held in academic medicine was straightforward: TB was a disease of the past, a relic best confined to historical case studies and footnotes about sanatorium-era public health. That assumption is now proving dangerously wrong — and the physicians trained under it are paying the price in missed diagnoses, delayed treatments, and patients who fall through the cracks of a system that was never taught to look for them.

Across the United States, tuberculosis cases have climbed steadily in recent years, with the Centers for Disease Control and Prevention reporting a notable post-pandemic resurgence driven by disruptions in screening programs, increased migration from high-burden countries, and the erosion of public health infrastructure. Yet inside the lecture halls and simulation labs of American medical schools, TB remains largely an afterthought — allocated, at many institutions, to fewer than three hours of dedicated instructional time across four years of training.

A Curriculum Built for a Different Era

The problem is not simply one of neglect. It is structural. Medical school curricula are designed by committees that must weigh an ever-expanding universe of clinical knowledge against a fixed number of instructional hours. In that competition, infectious diseases with declining domestic incidence — or perceived declining incidence — tend to lose ground to oncology, cardiology, and the chronic disease management that dominates American clinical practice.

Dr. Sandra Okafor, an infectious disease specialist who has taught at two accredited U.S. medical schools, describes the dynamic plainly. "When I arrived at my first faculty position, I was given forty-five minutes to cover TB for the entire second-year class," she says. "Forty-five minutes. That includes pathophysiology, clinical presentation, diagnostics, treatment, and public health reporting obligations. You cannot produce a competent clinician in forty-five minutes."

Okafor's experience is not unusual. A 2022 survey of infectious disease faculty at U.S. allopathic medical schools, conducted by a consortium of academic medical centers, found that fewer than 30 percent of programs offered dedicated TB modules beyond a single introductory lecture. The majority integrated tuberculosis content into broader respiratory or infectious disease blocks, where it competed for attention with influenza, pneumonia, COVID-19, and a dozen other conditions perceived as more immediately relevant.

The Cost of Comfortable Assumptions

The downstream consequences of this educational gap are becoming visible in emergency departments, primary care offices, and community health centers across the country. Clinicians who trained in the 1990s and 2000s — the era of TB's apparent retreat — report encountering younger colleagues who struggle to place TB on their differential diagnosis even when patients present with its classic constellation: persistent cough lasting more than three weeks, unexplained weight loss, night sweats, and low-grade fever.

"I've had residents look at a chest X-ray with classic upper-lobe cavitary lesions and not immediately think tuberculosis," says Dr. Marcus Vega, a pulmonologist practicing in Houston, Texas, a city that has seen significant TB case counts in recent years owing to its large immigrant and refugee populations. "They're not bad doctors. They were simply never taught to think about it reflexively."

This reflexive recognition — the clinical intuition that comes from repeated exposure to a diagnosis during training — is precisely what abbreviated curricula fail to build. Unlike a fact that can be recalled from a textbook, diagnostic instinct requires pattern recognition developed through case exposure, simulation, and mentorship. When TB cases appear in real clinical settings, physicians who have never encountered the disease in training are more likely to attribute symptoms to more familiar conditions: community-acquired pneumonia, lung cancer, or even COVID-19 sequelae.

The delays that result are not merely inconvenient. Tuberculosis is an airborne infectious disease. Every week a diagnosis is missed is a week during which a patient may be exposing family members, coworkers, and community contacts to Mycobacterium tuberculosis. In congregate settings — homeless shelters, correctional facilities, long-term care homes — a single delayed diagnosis can seed an outbreak that public health departments scramble to contain for months.

Diversity Blindness in Clinical Training

The educational gap carries a particular dimension of inequity when it comes to patient diversity. TB in the United States disproportionately affects foreign-born individuals, racial and ethnic minorities, people experiencing homelessness, and those living with HIV or diabetes. Yet medical school case libraries — the standardized patient scenarios and written clinical vignettes that anchor preclinical training — have historically underrepresented these populations.

When TB does appear in a training scenario, it is often presented as a straightforward textbook case in a patient whose demographic profile matches historical assumptions. The foreign-born construction worker, the elderly Vietnamese immigrant with a chronic cough, the unhoused individual whose weight loss has been attributed to substance use — these are the patients most likely to carry undiagnosed TB in American cities today, and they are the patients least likely to appear in the cases a medical student encounters before graduation.

"We are training physicians to recognize TB in patients who look like nineteenth-century sanitarium photographs," says Dr. Priya Nair, a medical education researcher at a northeastern university. "That is a failure of both epidemiological literacy and cultural competency."

What Reform Would Require

Experts in medical education and infectious disease are not without proposals. Several academic medical centers have begun piloting expanded TB curricula that integrate epidemiological context, diagnostic algorithms, and standardized patient encounters featuring diverse clinical presentations. The results, while preliminary, suggest that targeted exposure — even within constrained curricular time — significantly improves student performance on TB recognition assessments.

At the national level, advocates are calling on the Liaison Committee on Medical Education, the body that accredits U.S. medical schools, to establish minimum competency standards for tuberculosis recognition and management. Currently, no such standards exist. TB is not explicitly named among the conditions medical schools are required to address, leaving individual institutions to determine whether and how extensively to cover it.

Residency programs represent a second lever for reform. Internal medicine, family medicine, emergency medicine, and pediatric residencies — the training pathways through which most frontline physicians pass — could require dedicated TB case exposure and competency verification before board eligibility. Several infectious disease fellowship programs have already moved in this direction, but fellowship training reaches only a fraction of the physician workforce.

Technology offers supplementary tools. Online case modules, AI-assisted diagnostic training platforms, and telehealth consultations with TB specialists have all been proposed as mechanisms for extending TB education beyond the classroom. The CDC's Division of Tuberculosis Elimination has invested in some of these resources, though uptake among medical schools remains uneven.

An Ancient Disease Demands Modern Attention

Tuberculosis has accompanied human civilization for millennia. It shaped literature, claimed composers and poets, and drove the construction of public health systems that form the backbone of modern medicine. That it could be effectively forgotten in the training of twenty-first-century American physicians is, in its way, a remarkable institutional failure — and one with consequences that extend far beyond the lecture hall.

The physicians graduating today will practice for decades. They will encounter TB in communities that public health models may not anticipate, in patients whose presentations will not match the textbook, and in circumstances where a missed diagnosis carries consequences measured not in individual outcomes but in community transmission. Preparing them adequately is not a matter of nostalgia for an old disease. It is a matter of basic public health readiness.

The StopTB Initiative continues to advocate for comprehensive reforms in medical education as a foundational component of the broader effort to eliminate tuberculosis in the United States. Recognizing the disease is the first step. Teaching the next generation of physicians to do so is a responsibility the medical education system can no longer defer.